F&S reports
F S Rep
· ISSN (e) 2666-3341
· 131 papers in corpus
observational
2023
OBJECTIVE: To investigate barriers in accessing care for infertility in Mexico, because little is known about this issue for low and middle-income countries, which comprise 80% of the world's population. DESIGN: Cross-sectional analysis. …
observational
2023
OBJECTIVE: To identify independent risk factors for placenta accreta spectrum among pregnancies conceived with assisted reproductive technology. DESIGN: Retrospective cohort study. SETTING: Tertiary hospital. PATIENTS: Individuals who co…
observational
2023
OBJECTIVE: To determine if an association exists between body mass index (BMI) and fecundity after intrauterine insemination (IUI). DESIGN: Retrospective cohort study. SETTING: Academic-based fertility clinic. PATIENTS: Patients undergoi…
observational
2023
OBJECTIVE: To evaluate the association between body mass index (BMI) and good perinatal outcomes after in vitro fertilization (IVF) among women with polycystic ovary syndrome (PCOS). DESIGN: Retrospective cohort study using 2012-2015 Socie…
review
2023
This book chapter presents the most important clinical aspects concerning the gonadotropin-releasing hormone antagonist cetrorelix and its importance in reproductive medicine. After an overview of the historical milestones in the developmen…
review
2023
Gonadotropin-releasing hormone (GnRH) is central to the control of the entire hypothalamic-pituitary-gonadal axis. Manipulation of GnRH, in turn, regulates pituitary response and ovarian hormone production. Gonadotropin-releasing hormone an…
review
2023
Leuprolide acetate is the first GnRH agonist that entered clinical development after the discovery of the native GnRH. Several long-acting depot formulations of leuprolide acetate (ranging from 1-month to 6-month intramuscular injections) h…
review
2023
Elagolix is the first oral gonadotropin-releasing hormone antagonist that entered clinical development and received regulatory approval for the management of women with endometriosis and heavy menstrual bleeding associated with uterine fibr…
rct
2023
OBJECTIVE: To compare the oocyte yield between follicular-phase stimulation (FPS) and luteal-phase stimulation (LPS) in suboptimal responders. DESIGN: Prospective, randomized, crossover clinical trial. PATIENTS: Forty-one patients with in…
review
2023
Treatment of uterine fibroids (UF) and endometriosis (EM) has relied on the surgical skills of gynecologists to improve symptoms and potentially alter the course of these debilitating diseases. Medical management of symptoms for both diseas…
other
2023
In this article, I provide a narrative remembrance of the many early proof-of-concept studies that were performed at the Jones Institute for Reproductive Medicine in the late 1980s and early 1990s. A group, led by the late Dr. Gary Hodgen, …
observational
2023
OBJECTIVE: To determine the relationship between prior obstetrical history and gestational age at delivery in a twin pregnancy. DESIGN: Retrospective cohort study using the United States Society for Assisted Reproductive Technology Clinic …
other
2023
review
2023
Ganirelix is a gonadotropin-releasing hormone (GnRH) antagonist with high antagonistic activity that blocks the GnRH receptor by competitive binding. A daily dose of 0.25 mg of ganirelix was sel5ected after a phase II study because it was t…
review
2023
Treatment of heavy menstrual bleeding associated with uterine fibroids (UF) is evolving. Historically, treatment options were limited to predominantly invasive surgery; today, conservative and novel oral medical treatments are widely availa…
other
2023
observational
2023
OBJECTIVE: To address the knowledge gap surrounding herbal medicine and supplement usage patterns and supplement-prescription medication interactions among patients seeking treatment for infertility. DESIGN: Cross-sectional survey study. …
other
2023
OBJECTIVE: We report a case of an accessory cavitated uterine mass (ACUM) in a patient with infertility and chronic pelvic pain. In addition, we summarize the literature to better characterize ACUM diagnosis and management. DESIGN: A compr…
other
2023
OBJECTIVE: To describe the initiation, integration, and costs of reduced-cost infertility services within the maternal health department of a public hospital in a low-income country. DESIGN: Retrospective review of the clinical and laborat…
other
2023
OBJECTIVE: To compare the ongoing pregnancy rates (OPRs) for subcutaneous progesterone (SC-P) to intramuscular progesterone (IM-P) in hormone replacement therapy used in frozen embryo transfer (FET) cycles. DESIGN: Prospective nonrandomize…
review
2023
Although lifestyle factors such as diet, cigarette smoking, and alcohol consumption are increasingly recognized as important contributors to the risk of subfertility, the role of exercise in fertility remains less clear. As such, it is chal…
review
2022
Infertility affects over 6 million people in the United States and has been shown to disproportionally affect minority patient populations. Asian American infertility is a particularly understudied area of research. This mini review article…
observational
2022
OBJECTIVE: To describe the prevalence and treatment characteristics of assisted reproductive technology (ART) cycles involving specific male factor infertility diagnoses in the United States. DESIGN: Cross-sectional analysis of ART cycles …
observational
2022
OBJECTIVE: To investigate cumulative live birth rates (CLBRs) in cycles with and without preimplantation genetic testing for aneuploidy (PGT-A) among patients aged <35 and 35-37 years. DESIGN: Retrospective cohort study. SETTING: Society …
observational
2022
OBJECTIVE: To investigate the impact of chemotherapy on the uterus. DESIGN: Cross-sectional pilot study. SETTING: Single university fertility clinic. PATIENTS: Twelve patients with a history of alkylating agent chemotherapy exposure afte…